Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

July 17, 2017

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Spinocerebellar AtaxiasCerebellar AtaxiaNucleotide Repeat Disease

Interventions

OTHER

Specimen collection

Blood, urine, stool, cerebrospinal fluid, and skin biopsy may be collected

Trial Locations (1)

RECRUITING

Mayo Clinic in Florida, Jacksonville